The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Functions of intermediate filaments in neuronal development and disease
Abstract
Five major types of intermediate filament (IF) proteins are expressed in mature neurons: the three neurofilament proteins (NF‐L, NF‐M, and NF‐H), α‐internexin, and peripherin. While the differential expression of IF genes during embryonic development suggests potential functions of these proteins in axogenesis, none of the IF gene knockout experiments in mice caused gross developmental defects of the nervous system. Yet, deficiencies in neuronal IF proteins are not completely innocuous. Substantial developmental loss of motor axons was detected in mice lacking NF‐L and in double knockout NF‐M;NF‐H mice, supporting the view of a role for IFs in axon stabilization. Moreover, the absence of peripherin resulted in ≈30% loss of small sensory axons. Mice lacking NF‐L had a scarcity of IF structures and exhibited a severe axonal hypotrophy, causing up to 50% reduction in conduction velocity, a feature that would be very detrimental for large animal species. Unexpectedly, the NF‐M rather than NF‐H protein turned out to be required for proper radial growth of large myelinated axons. Studies with transgenic mice suggest that some types of IF accumulations, reminiscent of those found in amyotrophic lateral sclerosis (ALS), can have deleterious effects and even cause neurodegeneration. Additional evidence for the involvement of IFs in pathogenesis came from the recent discovery of neurofilament gene mutations linked to ALS and Charcot‐Marie‐Tooth disease (CMT2E). Conversely, we discuss how certain types of perikaryal neurofilament aggregates might confer protection in motor neuron disease. © 2003 Wiley Periodicals, Inc. J Neurobiol 58: 131–148, 2004
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CNS stem cells express a new class of intermediate filament protein
Lendahl, U., Zimmerman, L. B., & McKay, R. D. G. (1990) · Cell · doi:10.1016/0092-8674(90)90662-x · Cited by 3,151
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
The Fine Structure of the Nervous System.
TENNYSON, V. M. (1970) · Archives of Neurology · doi:10.1001/archneur.1970.00480240094019 · Cited by 1,948
The Fine Structure of the Nervous System: Neurons and Their Supporting Cells, 3rd Ed.
Afifi, A. K. (1991) · Neurology · doi:10.1212/wnl.41.9.1535-b · Cited by 1,045
A Structural Scaffolding of Intermediate Filaments in Health and Disease
Fuchs, E., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.279.5350.514 · Cited by 1,012
Hoffman, P. N., & Lasek, R. J. (1975) · The Journal of cell biology · doi:10.1083/jcb.66.2.351 · Cited by 937
de Waegh, S. M., Lee, V. M.-Y., & Brady, S. T. (1992) · Cell · doi:10.1016/0092-8674(92)90183-d · Cited by 742
Innate immunity: the missing link in neuroprotection and neurodegeneration?
Nguyen, M. D., Julien, J.-P., & Rivest, S. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn752 · Cited by 701
Self-citationCôté, F., Collard, J.-F., & Julien, J.-P. (1993) · Cell · doi:10.1016/0092-8674(93)90158-m · Cited by 551
Self-citation
Cited by
Matrix elasticity directs stem cell lineage specification
Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006) · Cell · doi:10.1016/j.cell.2006.06.044 · Cited by 13,915
Axonal transport deficits and neurodegenerative diseases
Millecamps, S., & Julien, J.-P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3380 · Cited by 755
Self-citationNeurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
Petzold, A. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.015 · Cited by 688
Arthur, A., Rychkov, G., Shi, S., Koblar, S. A., & Gronthos, S. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0979 · Cited by 613
Barmada, S. J., Skibinski, G., Korb, E., Rao, E. J., Wu, J. Y., & Finkbeiner, S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4988-09.2010 · Cited by 554
Vimentin-Dependent Spatial Translocation of an Activated MAP Kinase in Injured Nerve
Perlson, E., Hanz, S., Ben-Yaakov, K., Segal-Ruder, Y., Seger, R., & Fainzilber, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.023 · Cited by 505
Intermediate Filament Proteins and Their Associated Diseases
Omary, M. B., Coulombe, P. A., & McLean, W. H. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040319 · Cited by 486
Teo, B. K. K., Wong, S. T., Lim, C. K., Kung, T. Y. S., Yap, C. H., Ramagopal, Y., Romer, L. H., & Yim, E. K. F. (2013) · ACS Nano · doi:10.1021/nn304966z · Cited by 419
Nestin-expressing progenitor cells: function, identity and therapeutic implications
Bernal, A., & Arranz, L. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2794-z · Cited by 389
Szeverenyi, I., Cassidy, A. J., Chung, C. W., Lee, B. T. K., Common, J. E. A., Ogg, S. C., Chen, H., Sim, S. Y., Goh, W. L. P., Ng, K. W., et al. (2008) · Human Mutation · doi:10.1002/humu.20652 · Cited by 372
Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds
Coulombe, P. A., & Wong, P. (2004) · Nature Cell Biology · doi:10.1038/ncb0804-699 · Cited by 353
TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein
Strong, M. J., Volkening, K., Hammond, R., Yang, W., Strong, W., Leystra-Lantz, C., & Shoesmith, C. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.03.007 · Cited by 349
miRNA malfunction causes spinal motor neuron disease
Haramati, S., Chapnik, E., Sztainberg, Y., Eilam, R., Zwang, R., Gershoni, N., McGlinn, E., Heiser, P. W., Wills, A.-M., Wirguin, I., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006151107 · Cited by 327
Kim, S., & Coulombe, P. A. (2007) · Genes & Development · doi:10.1101/gad.1552107 · Cited by 316
‘Heads and tails’ of intermediate filament phosphorylation: multiple sites and functional insights
Omary, M. B., Ku, N.-O., Tao, G.-Z., Toivola, D. M., & Liao, J. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.05.008 · Cited by 294
Eftekhari, S., Warfvinge, K., Blixt, F. W., & Edvinsson, L. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2013.03.010 · Cited by 260
Genetics of familial and sporadic amyotrophic lateral sclerosis
Gros-Louis, F., Gaspar, C., & Rouleau, G. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.01.004 · Cited by 255
Fabrication and cellular compatibility of aligned chitosan–PCL fibers for nerve tissue regeneration
Cooper, A., Bhattarai, N., & Zhang, M. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.02.008 · Cited by 254
Moisse, K., Volkening, K., Leystra-Lantz, C., Welch, I., Hill, T., & Strong, M. J. (2009) · Brain Research · doi:10.1016/j.brainres.2008.10.021 · Cited by 210
Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications
Cozzolino, M., Ferri, A., & Teresa Carrì, M. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1760 · Cited by 156
Induction of neural differentiation in rat C6 glioma cells with taxol
Chao, C., Kan, D., Lo, T., Lu, K., & Chien, C. (2015) · Brain and Behavior · doi:10.1002/brb3.414 · Cited by 28
Edwards, A. V. G., Edwards, G. J., Schwämmle, V., Saxtorph, H., & Larsen, M. R. (2014) · Journal of Proteome Research · doi:10.1021/pr4002977 · Cited by 22
Metadata
- Authors
- Lariviere, R. C., & Julien, J.
- Venue
- Journal of Neurobiology
- Publisher
- Wiley
- Published
- 2003-10-29
- Volume
- 58
- Issue
- 1
- Pages
- 131-148
- ISSN
- 0022-3034 (ISSN-L)
- 1097-4695
- OpenAlex
- W2151330068
- Cited by
- 333
- References
- 119
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.